Request for Covid-19 Impact Assessment of this Report
The United States Efavirenz market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Efavirenz market, reaching US$ million by the year 2028. As for the Europe Efavirenz landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Efavirenz players cover Bristol-Myers Squibb, Teva, Mylan, and Aurobindo Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Efavirenz market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Single Efavirenz
Two-drug combination
Three-drug combination
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Adults
Children
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bristol-Myers Squibb
Teva
Mylan
Aurobindo Pharma
Cipla
Macleods Pharmaceuticals
Hetero
Strides Pharma
Gilead Sciences
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Efavirenz Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Efavirenz by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Efavirenz by Country/Region, 2017, 2022 & 2028
2.2 Efavirenz Segment by Type
2.2.1 Single Efavirenz
2.2.2 Two-drug combination
2.2.3 Three-drug combination
2.3 Efavirenz Sales by Type
2.3.1 Global Efavirenz Sales Market Share by Type (2017-2022)
2.3.2 Global Efavirenz Revenue and Market Share by Type (2017-2022)
2.3.3 Global Efavirenz Sale Price by Type (2017-2022)
2.4 Efavirenz Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Efavirenz Sales by Application
2.5.1 Global Efavirenz Sale Market Share by Application (2017-2022)
2.5.2 Global Efavirenz Revenue and Market Share by Application (2017-2022)
2.5.3 Global Efavirenz Sale Price by Application (2017-2022)
3 Global Efavirenz by Company
3.1 Global Efavirenz Breakdown Data by Company
3.1.1 Global Efavirenz Annual Sales by Company (2020-2022)
3.1.2 Global Efavirenz Sales Market Share by Company (2020-2022)
3.2 Global Efavirenz Annual Revenue by Company (2020-2022)
3.2.1 Global Efavirenz Revenue by Company (2020-2022)
3.2.2 Global Efavirenz Revenue Market Share by Company (2020-2022)
3.3 Global Efavirenz Sale Price by Company
3.4 Key Manufacturers Efavirenz Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Efavirenz Product Location Distribution
3.4.2 Players Efavirenz Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Efavirenz by Geographic Region
4.1 World Historic Efavirenz Market Size by Geographic Region (2017-2022)
4.1.1 Global Efavirenz Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Efavirenz Annual Revenue by Geographic Region
4.2 World Historic Efavirenz Market Size by Country/Region (2017-2022)
4.2.1 Global Efavirenz Annual Sales by Country/Region (2017-2022)
4.2.2 Global Efavirenz Annual Revenue by Country/Region
4.3 Americas Efavirenz Sales Growth
4.4 APAC Efavirenz Sales Growth
4.5 Europe Efavirenz Sales Growth
4.6 Middle East & Africa Efavirenz Sales Growth
5 Americas
5.1 Americas Efavirenz Sales by Country
5.1.1 Americas Efavirenz Sales by Country (2017-2022)
5.1.2 Americas Efavirenz Revenue by Country (2017-2022)
5.2 Americas Efavirenz Sales by Type
5.3 Americas Efavirenz Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Efavirenz Sales by Region
6.1.1 APAC Efavirenz Sales by Region (2017-2022)
6.1.2 APAC Efavirenz Revenue by Region (2017-2022)
6.2 APAC Efavirenz Sales by Type
6.3 APAC Efavirenz Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Efavirenz by Country
7.1.1 Europe Efavirenz Sales by Country (2017-2022)
7.1.2 Europe Efavirenz Revenue by Country (2017-2022)
7.2 Europe Efavirenz Sales by Type
7.3 Europe Efavirenz Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Efavirenz by Country
8.1.1 Middle East & Africa Efavirenz Sales by Country (2017-2022)
8.1.2 Middle East & Africa Efavirenz Revenue by Country (2017-2022)
8.2 Middle East & Africa Efavirenz Sales by Type
8.3 Middle East & Africa Efavirenz Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Efavirenz
10.3 Manufacturing Process Analysis of Efavirenz
10.4 Industry Chain Structure of Efavirenz
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Efavirenz Distributors
11.3 Efavirenz Customer
12 World Forecast Review for Efavirenz by Geographic Region
12.1 Global Efavirenz Market Size Forecast by Region
12.1.1 Global Efavirenz Forecast by Region (2023-2028)
12.1.2 Global Efavirenz Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Efavirenz Forecast by Type
12.7 Global Efavirenz Forecast by Application
13 Key Players Analysis
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Information
13.1.2 Bristol-Myers Squibb Efavirenz Product Offered
13.1.3 Bristol-Myers Squibb Efavirenz Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bristol-Myers Squibb Main Business Overview
13.1.5 Bristol-Myers Squibb Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Efavirenz Product Offered
13.2.3 Teva Efavirenz Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Efavirenz Product Offered
13.3.3 Mylan Efavirenz Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Aurobindo Pharma
13.4.1 Aurobindo Pharma Company Information
13.4.2 Aurobindo Pharma Efavirenz Product Offered
13.4.3 Aurobindo Pharma Efavirenz Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Aurobindo Pharma Main Business Overview
13.4.5 Aurobindo Pharma Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Efavirenz Product Offered
13.5.3 Cipla Efavirenz Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Macleods Pharmaceuticals
13.6.1 Macleods Pharmaceuticals Company Information
13.6.2 Macleods Pharmaceuticals Efavirenz Product Offered
13.6.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Macleods Pharmaceuticals Main Business Overview
13.6.5 Macleods Pharmaceuticals Latest Developments
13.7 Hetero
13.7.1 Hetero Company Information
13.7.2 Hetero Efavirenz Product Offered
13.7.3 Hetero Efavirenz Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hetero Main Business Overview
13.7.5 Hetero Latest Developments
13.8 Strides Pharma
13.8.1 Strides Pharma Company Information
13.8.2 Strides Pharma Efavirenz Product Offered
13.8.3 Strides Pharma Efavirenz Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Strides Pharma Main Business Overview
13.8.5 Strides Pharma Latest Developments
13.9 Gilead Sciences
13.9.1 Gilead Sciences Company Information
13.9.2 Gilead Sciences Efavirenz Product Offered
13.9.3 Gilead Sciences Efavirenz Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Gilead Sciences Main Business Overview
13.9.5 Gilead Sciences Latest Developments
14 Research Findings and Conclusion
Table 1. Efavirenz Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Efavirenz Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Single Efavirenz
Table 4. Major Players of Two-drug combination
Table 5. Major Players of Three-drug combination
Table 6. Global Efavirenz Sales by Type (2017-2022) & (K Units)
Table 7. Global Efavirenz Sales Market Share by Type (2017-2022)
Table 8. Global Efavirenz Revenue by Type (2017-2022) & ($ million)
Table 9. Global Efavirenz Revenue Market Share by Type (2017-2022)
Table 10. Global Efavirenz Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Efavirenz Sales by Application (2017-2022) & (K Units)
Table 12. Global Efavirenz Sales Market Share by Application (2017-2022)
Table 13. Global Efavirenz Revenue by Application (2017-2022)
Table 14. Global Efavirenz Revenue Market Share by Application (2017-2022)
Table 15. Global Efavirenz Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Efavirenz Sales by Company (2020-2022) & (K Units)
Table 17. Global Efavirenz Sales Market Share by Company (2020-2022)
Table 18. Global Efavirenz Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Efavirenz Revenue Market Share by Company (2020-2022)
Table 20. Global Efavirenz Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Efavirenz Producing Area Distribution and Sales Area
Table 22. Players Efavirenz Products Offered
Table 23. Efavirenz Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Efavirenz Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Efavirenz Sales Market Share Geographic Region (2017-2022)
Table 28. Global Efavirenz Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Efavirenz Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Efavirenz Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Efavirenz Sales Market Share by Country/Region (2017-2022)
Table 32. Global Efavirenz Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Efavirenz Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Efavirenz Sales by Country (2017-2022) & (K Units)
Table 35. Americas Efavirenz Sales Market Share by Country (2017-2022)
Table 36. Americas Efavirenz Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Efavirenz Revenue Market Share by Country (2017-2022)
Table 38. Americas Efavirenz Sales by Type (2017-2022) & (K Units)
Table 39. Americas Efavirenz Sales Market Share by Type (2017-2022)
Table 40. Americas Efavirenz Sales by Application (2017-2022) & (K Units)
Table 41. Americas Efavirenz Sales Market Share by Application (2017-2022)
Table 42. APAC Efavirenz Sales by Region (2017-2022) & (K Units)
Table 43. APAC Efavirenz Sales Market Share by Region (2017-2022)
Table 44. APAC Efavirenz Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Efavirenz Revenue Market Share by Region (2017-2022)
Table 46. APAC Efavirenz Sales by Type (2017-2022) & (K Units)
Table 47. APAC Efavirenz Sales Market Share by Type (2017-2022)
Table 48. APAC Efavirenz Sales by Application (2017-2022) & (K Units)
Table 49. APAC Efavirenz Sales Market Share by Application (2017-2022)
Table 50. Europe Efavirenz Sales by Country (2017-2022) & (K Units)
Table 51. Europe Efavirenz Sales Market Share by Country (2017-2022)
Table 52. Europe Efavirenz Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Efavirenz Revenue Market Share by Country (2017-2022)
Table 54. Europe Efavirenz Sales by Type (2017-2022) & (K Units)
Table 55. Europe Efavirenz Sales Market Share by Type (2017-2022)
Table 56. Europe Efavirenz Sales by Application (2017-2022) & (K Units)
Table 57. Europe Efavirenz Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Efavirenz Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Efavirenz Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Efavirenz Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Efavirenz Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Efavirenz Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Efavirenz Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Efavirenz Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Efavirenz Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Efavirenz
Table 67. Key Market Challenges & Risks of Efavirenz
Table 68. Key Industry Trends of Efavirenz
Table 69. Efavirenz Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Efavirenz Distributors List
Table 72. Efavirenz Customer List
Table 73. Global Efavirenz Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Efavirenz Sales Market Forecast by Region
Table 75. Global Efavirenz Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Efavirenz Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Efavirenz Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Efavirenz Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Efavirenz Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Efavirenz Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Efavirenz Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Efavirenz Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Efavirenz Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Efavirenz Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Efavirenz Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Efavirenz Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Efavirenz Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Efavirenz Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Efavirenz Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Efavirenz Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Efavirenz Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Efavirenz Revenue Market Share Forecast by Application (2023-2028)
Table 93. Bristol-Myers Squibb Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 94. Bristol-Myers Squibb Efavirenz Product Offered
Table 95. Bristol-Myers Squibb Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Bristol-Myers Squibb Main Business
Table 97. Bristol-Myers Squibb Latest Developments
Table 98. Teva Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 99. Teva Efavirenz Product Offered
Table 100. Teva Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. Teva Main Business
Table 102. Teva Latest Developments
Table 103. Mylan Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 104. Mylan Efavirenz Product Offered
Table 105. Mylan Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. Mylan Main Business
Table 107. Mylan Latest Developments
Table 108. Aurobindo Pharma Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 109. Aurobindo Pharma Efavirenz Product Offered
Table 110. Aurobindo Pharma Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. Aurobindo Pharma Main Business
Table 112. Aurobindo Pharma Latest Developments
Table 113. Cipla Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 114. Cipla Efavirenz Product Offered
Table 115. Cipla Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Cipla Main Business
Table 117. Cipla Latest Developments
Table 118. Macleods Pharmaceuticals Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 119. Macleods Pharmaceuticals Efavirenz Product Offered
Table 120. Macleods Pharmaceuticals Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Macleods Pharmaceuticals Main Business
Table 122. Macleods Pharmaceuticals Latest Developments
Table 123. Hetero Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 124. Hetero Efavirenz Product Offered
Table 125. Hetero Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Hetero Main Business
Table 127. Hetero Latest Developments
Table 128. Strides Pharma Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 129. Strides Pharma Efavirenz Product Offered
Table 130. Strides Pharma Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Strides Pharma Main Business
Table 132. Strides Pharma Latest Developments
Table 133. Gilead Sciences Basic Information, Efavirenz Manufacturing Base, Sales Area and Its Competitors
Table 134. Gilead Sciences Efavirenz Product Offered
Table 135. Gilead Sciences Efavirenz Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Gilead Sciences Main Business
Table 137. Gilead Sciences Latest Developments
List of Figures
Figure 1. Picture of Efavirenz
Figure 2. Efavirenz Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Efavirenz Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Efavirenz Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Efavirenz Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Single Efavirenz
Figure 10. Product Picture of Two-drug combination
Figure 11. Product Picture of Three-drug combination
Figure 12. Global Efavirenz Sales Market Share by Type in 2021
Figure 13. Global Efavirenz Revenue Market Share by Type (2017-2022)
Figure 14. Efavirenz Consumed in Adults
Figure 15. Global Efavirenz Market: Adults (2017-2022) & (K Units)
Figure 16. Efavirenz Consumed in Children
Figure 17. Global Efavirenz Market: Children (2017-2022) & (K Units)
Figure 18. Global Efavirenz Sales Market Share by Application (2017-2022)
Figure 19. Global Efavirenz Revenue Market Share by Application in 2021
Figure 20. Efavirenz Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Efavirenz Revenue Market Share by Company in 2021
Figure 22. Global Efavirenz Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Efavirenz Revenue Market Share by Geographic Region in 2021
Figure 24. Global Efavirenz Sales Market Share by Region (2017-2022)
Figure 25. Global Efavirenz Revenue Market Share by Country/Region in 2021
Figure 26. Americas Efavirenz Sales 2017-2022 (K Units)
Figure 27. Americas Efavirenz Revenue 2017-2022 ($ Millions)
Figure 28. APAC Efavirenz Sales 2017-2022 (K Units)
Figure 29. APAC Efavirenz Revenue 2017-2022 ($ Millions)
Figure 30. Europe Efavirenz Sales 2017-2022 (K Units)
Figure 31. Europe Efavirenz Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Efavirenz Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Efavirenz Revenue 2017-2022 ($ Millions)
Figure 34. Americas Efavirenz Sales Market Share by Country in 2021
Figure 35. Americas Efavirenz Revenue Market Share by Country in 2021
Figure 36. United States Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Efavirenz Sales Market Share by Region in 2021
Figure 41. APAC Efavirenz Revenue Market Share by Regions in 2021
Figure 42. China Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Efavirenz Sales Market Share by Country in 2021
Figure 49. Europe Efavirenz Revenue Market Share by Country in 2021
Figure 50. Germany Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Efavirenz Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Efavirenz Revenue Market Share by Country in 2021
Figure 57. Egypt Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Efavirenz Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Efavirenz in 2021
Figure 63. Manufacturing Process Analysis of Efavirenz
Figure 64. Industry Chain Structure of Efavirenz
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...